Program

Program at glance

May 26(Sat.)

Registration8:30-16:00

May 26(Sat.)  TAKANE A

Opening Remarks9:45-9:50

Koji Hasegawa, Chair of 23rd ISCP Kyoto 2018, President of ISCP

Symposium9:50-11:00

Future Pharmacotherapy for Atherosclerosis: Basic Science for the Clinician

Chairpersons:

Kensuke Noma, Hiroshima, Japan
Morihiro Matsuda, Kure, Japan

Speakers (14 minutes talk followed by 3.5 minutes Q&A for each speaker):

Tatsuya Sawamura, Nagano, Japan
“Modified Lipoproteins and LOX-1 in Cardiovascular Disease”

Noboru Ashida, Kyoto, Japan
“Role of inflammatory signaling in vascular calcification”

Tetsuya Matoba, Fukuoka, Japan
“Ezetimibe ameliorates coronary endothelial dysfunction through decreases in oxysterols”

Koh Ono, Kyoto, Japan
SREBF1/MicroRNA-33b axis exhibits potent effect on unstable atherosclerotic plaque   formation in vivo

Joint Panel Discussion with ESC Working Group on
Cardiovascular Pharmacotherapy
11:00-12:20

Cardiac and Systemic Linkage for the Control of Hypertension

Chairpersons:

Heinz Drexel, Austria
Koji Hasegawa, Kyoto, Japan

Speakers (15 minutes talk for each followed by discussion of 20 minutes by all):

Thomas Kahan, Sweden
“Hypertensive heart disease”

Stefan Agewall, Norway
“Effective at last – The new glucose-lowering drugs that reduce CV events”

Celso Amodeo, Brazil
“Resistant hypertension”

Junichi Oyama, Saga, Japan
“Sleep apnea syndrome”

Lunch Box Seminar supported by GSK12:30-13:30

Pulmonary Hypertension

Chairpersons:

Atsushi Nakano, Japan

Speakers:

Carlos Jardim, Brazil
Hiromi Matsubara, Okayama, Japan

Panel Discussion13:40-15:00

Prevention of Atherosclerotic Events by Targeting Lipid Metabolism and Inflammation

Chairpersons:

Juan Carlos Kaski, UK
Celso Amodeo, Brazil

Speakers (20 minutes talk for each followed by discussion of 20 minutes by all):

Heinz Drexel, Austria
“PCSK9-inhibitors for which patient?”

Masaaki Kawashiri, Kanazawa, Japan
“Familiar Hypercholesterolemia”

Alberto Lorenzatti, Argentina
“Anti-inflammatory drugs: niche treatment or broad application?”

Coffee Break15:00-15:15

Meet the Experts - pharmacotherapy challenges -15:15-16:05

Modulators:

Koji Hasegawa and Juan Carlos Kaski

Discussants:

George Dan, Thomas Kahan, Antoni Martinez Rubio, Felipe Martìnez.

Topics to be discussed (12.5 minutes each):

  1. What is the best strategy for the management of HFpEF?
  2. Should we use a same type of anticoagulant for all patients with AF?
  3. PCSK9 Inhibitors: Indications and timing
  4. Are β-blockers useful for the management of systemic hypertension?

Coffee Break16:05-16:20

Joint WHF/ISCP Plenary Session16:20-17:40

Global Cardiovascular Risk Management to Achieve ‘25 by 25’

Chairs and Modulateors:

Jean-Luc Eiselé, CEO, World Heart Federation
Koji Hasegawa, President, ISCP

Opening Remarks:

Chuichi Kawai, Past President of World Heart Federation

Speakers and Discussants (10 minutes speak for each followed by discussion of 30 minutes):

Katsuyuki Miura, Shiga, Japan
“Global Epidemiology in Cardiovascular Risk Factors”

Alvaro S. Liprandi, Argentina
“Roadmaps to Achieve ‘25 by 25’ ─Global and Regional Coalitions─”

Shinji Koba, Tokyo.Japan
“The Role of Exercise for Cardiovascular Prevention”

Maki Komiyama, Kyoto, Japan
“Smoking and depression in Cardiovascular Disease”

Edgardo Escobar, Chile
“Telemedicine to Reduce Mortality in Heart Attacks”

Henry N. Neufeld Memorial Award Lecture17:40-18:10

Precision Medicine: Molecular Phenotyping in Cardiovascular Pharmacotherapy

Chairperson:

Masayuki Yoshida, Tokyo Japan

Lecturer:

Lina Badimon, Catalan Institute of Cardiovascular Sciences (ICCC)

Spanish National Research Council (CSIC)

May 26(Sat.)  TAKANE B

Symposium9:50-11:00

Reprograming and Regeneration of the Heart: Basic Science for the Clinician

Chairpersons:

Tatsuya Morimoto, Shizuoka Japan
Shuhei Tomita, Osaka, Japan

Speakers (14 minutes talk followed by 3.5 minutes Q&A for each speaker):

Teruhisa Kawamura, Kyoto, Japan
“Dissecting the Process of Metabolic Shift during iPS Cell Reprogramming from Fibroblasts”

Junko Kurokawa, Shizuoka, Japan
“Electrophysiological maturation of human iPS-derived cardiomyocytes”

Masaki Ieda, Ibaraki, Japan
“Direct Cardiac Reprogramming and Heart Regeneration”

Takeru Makiyama, Kyoto, Japan
“Modelling long-QT syndrome with human iPS cells and development of new
 pharmacotherapies”

Joint session of ISCP and ISCMF11:00-12:20

Recent Advances in Cardiomyopathies, Myocarditis and Heart Failure

Chairpersons:

Mario Maranhao, Brazil
Peter Schultheiss, Germany

Speakers (15 minutes talk followed by 5 minutes Q&A for each speaker):

Akira Matsumori, Kyoto, Japan
“New biomarkers of inflammation and cardiovascular risk”

Peter Liu, Ottawa, Canada
“Genetic and Protein Biomarkers in the Diagnosis and Management of
 Cardiomyopathies and Heart Failure.”

Andre Keren, Israel
“Clinical implications of the new European definition of dilated cardiomyopathy”

Leslie Cooper, USA
“The Evolving Role for Nuclear Imaging in Unexplained Cardiomyopathy”

Peter Schultheiss, Germany
“Modelling long-QT syndrome with human iPS cells and development of new pharmacotherapies”

Seminar with Lunch Box12:30-13:30

Up-to-date Topics of Atrial Fibrillation and Anti-coagulant Therapy

Chairperson:

Felipe Martinez, Argentina

Speaker:

Masaharu Akao, Kyoto, Japan
“Risk stratification of atrial fibrillation in Asia”

Dalmo Moreira, Brazi
“Is there a role for the nonvit K antagonist in the prevention of atrial fibrillation? ”

Symposium13:40-15:00

Pharmacotherapy and Life-style Modification for Heart Failure: the Present and the Future

Chairpersons:

Shigetake Sasayama, Kyoto, Japan
Yasushi Fujio, Osaka, Japan

Speakers (20 minutes talk followed by 6 minutes Q&A for each speaker):

Sang Hong Baek, Korea
“Myocardial fibrosis and new options for treatment”

Felipe Martinez, Argentina
“New drugs in heart failure: more of the same or the beginning of a new era?”

Takuya Kishi, Fukuoka, Japan
“Cardiac linkage with brain and autonomic nervous system”

Coffee Break15:00-15:15

Symposium15:15-16:15

Cardiovascular Imaging Guiding Pharmacotherapy

Chairpersons:

Alberto Lorenzatti, Argentina
Masataka Sata, Tokushima, Japan

Speakers (15 minutes talk followed by 5 minutes Q&A for each speaker):

Augusto Gallino, Switzerland
“Role of imaging in developing new drugs”

Takashi Akasaka, Wakayama, Japan
“Optical coherence tomography”

Mitsuyasu Terashima, Aiti, Japan
“Intravascular Ultrasound”

May 26(Sat.)  KOCHO, SHIDARE

Poster Session18:20-19:20

May 26(Sat.) TAKANE A and TAKANE B

Reception Party19:30-

May 27(Sun.)

Registration8:30-16:00

May 27(Sun.)  TAKANE A, TAKANE B, KOCHO

May 27(Sun.)  TAKANE A

Panel Discussion13:40-14:40

Controversies in Anti-coagulant Therapy in Atrial Fibrillation and Venous Thromboembolism

Chairpersons:

George A. Dan, Romania
Takanori Ikeda, Tokyo, Japan

Speakers (15 minutes each followed by discussion of 15 minutes by all):

Ali Oto, Turkey
“Risk stratification of stroke in AF”

Antoni Martinez-Rubio Barcelona, Spain
“DOAC for AF”

Shinji Hisatake, Tokyo, Japan
“DOAC for VTE”

Panel Discussion14:40-15:40

Treatment of Atrial Fibrillation: the Place of Antiarrhythmic Drugs

Chairpersons:

Ali Oto, Turkey
Atsushi Sugiyama, Tokyo, Japan

Speakers (20 minutes each followed by discussion of 20 minutes by all):

George A. Dan, Romania
“Antiarrhythmic drugs”

Naohiko Takahashi, Oita, Japan
“Inflammation in AF”

Joint Workshop with
Asian Pacific Society of Cardiology (APSC)
15:40-16:40

Prediction and Prevention of Sudden Cardiac Death and Syncope

Chairpersons:

Jiunn-Lee Lin, Taiwan (from APSC)
Nannette R. Rey, Philippine (from ISCP)

Speakers (15 minutes each followed by discussion of 15 minutes by all):

Anca Dan, Romania
“Syncope: Diagnosis and risk stratification”

Naohiko Takahashi, Oita, Japan
“Sudden cardiac death in J-wave syndrome”

Takanori Ikeda, Tokyo, Japan
“Prediction of sudden cardiac death”

Award Ceremony for Best Abstract Presentation16:40-17:00

Closing Remarks Augusto Gallino, Chair, 24th ISCP Switzerland 2019

May 27(Sun.)  TAKANE B

Symposium13:40-14:40

Drug Management of Coronary Vasospasm, Microvascular Angina and Takotsubo Cardiomyopathy

Chairpersons:

Masatoshi Fujita, Kyoto, Japan
Masataka Sata, Tokushima, Japan

Speakers (15 minutes talk followed by 5 minutes Q&A for each speaker):

Juan Carlos Kaski, UK
“Microvascular angina”

Sang Hong Baek, Korea
“Coronary vasospasm”

Yoshihiro Akashi, Kanagawa, Japan
“Takotsubo cardiomyopathy”

Joint Symposium with
Asian Pacific Society of Cardiology (APSC)
14:40-15:40

Biomarkers to Predict Acute Coronary Syndrome, Atherosclerosis and Heart Failure

Chairpersons:

San-Jou Yeh, Taiwan (from APSC)
Jorge A. Sison, Philippine (from ISCP)

Speakers (15 minutes talk followed by 5 minutes Q&A for each speaker):

Bernard MY Cheung, Hong Kong
“Biomarkers for acute coronary syndrome - are they good enough?”

Augusto Gallino, Switzerland

Hiromichi Wada, Kyoto, Japan
“Vascular endothelial growth factor-C and mortality in patients with suspected coronary artery disease”

Symposium15:40-16:40

Anti-thrombotic Therapy during and after Coronary Intervention

Chairpersons:

Augusto Gallino, Switzerland
Doreen Tan, Singapore

Speakers (15 minutes talk followed by 5 minutes Q&A for each speaker):

Bernard MY Cheung, Hong Kong
“Resolving the controversy on optimal duration of dual antiplatelet therapy after coronary intervention”

Antoni Martinez-Rubio, Barcelona, Spain
“DOAC in coronary artery disease”

Isao Taguchi, Saitama, Japan
“Optimal anti-thrombotic therapy after PCI”

May 27(Sun.)  SHIDARE

Governor's Meeting10:30-13:30

May 27(Sun.)  KOCHO

World Tobacco No Day Memorial Session13:40-15:10

Tobacco and heart disease

Chairperson:

Keijiro Saku, Kyoto Japan
Tatsuya Morimoto, Shizuoka Japan

Speakers and Discussants (20 minutes each followed by discussion of 30 minutes by all)

Toyoaki Murohara, Aichi Japan
“Tobacco and cardiovascular disease”

Rei Goto, Tokyo Japan
“Cost-benefit Effectiveness on Smoking Cessation”

Lisa Demos, Australia
“Pharmacotherapy and Australian initiatives for smoking cessation”

Symposium15:10-16:30

Cardiac metabolism and mitochondria

Chairperson:

Satoaki Matoba, Kyoto Japan
Hiroshi Kondo, Kyoto Japan

Speakers (15 minutes talk followed by 5 minutes Q&A for each speaker)

Osamu Yamaguchi, Ehime Japan
“Mitochondria degradation as a novel therapeutic target for heart failure”

Masaya Tanno, Hokkaido,Japan
“Regulation of mitochondrial GSK-3β activity by kinases, phosphatases and a deacetylase: a key determinant for mitochondrial permeability transition ”

Ippei Shimizu, Niigata Japan
“The pathological role of brown adipose tissue dysfunction in cardio-metabolic disorders”

Atsushi Hoshino, Kyoto Japan
“Essential mitochondrial components to induce mitophagy”

  • HOME
  • Welcome Message
  • General Information
  • Organizing Committee
  • Program
  • Call for Abstracts
  • Registration
  • Venue & Access
  • WHY KYOTO
  • Link

Local information
in Japanese

日本医師会 生涯教育講座 単位が付与されました:
カリキュラムコードはこちら

本会参加により日本薬剤師研修センター集合研修会の6単位/2日間(一日のみの出席の場合は4単位)が取得できます。